| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
10,142 |
7,313 |
$1.02M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13,126 |
9,494 |
$773K |
| 59025 |
Fetal non-stress test |
3,702 |
2,343 |
$526K |
| 80053 |
Comprehensive metabolic panel |
30,154 |
21,412 |
$456K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,740 |
3,607 |
$379K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,395 |
1,623 |
$307K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,248 |
1,661 |
$254K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,371 |
2,902 |
$253K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
35,390 |
24,669 |
$225K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,231 |
9,541 |
$225K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,015 |
3,807 |
$190K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,498 |
10,573 |
$167K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,141 |
4,518 |
$148K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,619 |
3,415 |
$114K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,427 |
7,722 |
$97K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,794 |
1,417 |
$94K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,617 |
572 |
$93K |
| 83880 |
|
3,912 |
2,897 |
$91K |
| 36415 |
Collection of venous blood by venipuncture |
14,702 |
9,753 |
$91K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,256 |
878 |
$88K |
| 71045 |
Radiologic examination, chest; single view |
12,231 |
8,887 |
$80K |
| 71046 |
Radiologic examination, chest; 2 views |
4,601 |
3,524 |
$76K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,251 |
1,563 |
$71K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,781 |
2,536 |
$71K |
| 84484 |
|
9,937 |
6,234 |
$66K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
594 |
450 |
$62K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,764 |
4,228 |
$59K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,150 |
1,102 |
$58K |
| 81025 |
|
7,753 |
5,795 |
$53K |
| 11043 |
|
596 |
230 |
$52K |
| 81001 |
|
14,524 |
10,856 |
$45K |
| 82962 |
|
8,055 |
3,809 |
$44K |
| 83874 |
|
4,010 |
3,132 |
$43K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,722 |
1,976 |
$40K |
| 82077 |
|
2,495 |
1,623 |
$36K |
| 87040 |
|
4,324 |
2,348 |
$35K |
| 87420 |
|
3,500 |
2,725 |
$35K |
| 87070 |
|
1,859 |
1,341 |
$32K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,325 |
1,588 |
$31K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,131 |
2,359 |
$30K |
| 80061 |
Lipid panel |
2,853 |
2,219 |
$30K |
| 87081 |
|
3,432 |
3,112 |
$30K |
| 73630 |
|
1,376 |
1,072 |
$28K |
| 73560 |
|
1,452 |
1,142 |
$28K |
| 87077 |
|
3,200 |
2,410 |
$24K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,894 |
1,114 |
$24K |
| 73130 |
|
1,067 |
858 |
$24K |
| 83690 |
|
4,305 |
3,238 |
$24K |
| 82803 |
|
1,670 |
1,123 |
$22K |
| 81003 |
|
9,479 |
7,164 |
$21K |
| 87088 |
|
3,441 |
2,687 |
$21K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
554 |
399 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,985 |
2,291 |
$20K |
| 78453 |
|
174 |
159 |
$19K |
| 83605 |
|
2,710 |
1,802 |
$18K |
| 86901 |
|
931 |
666 |
$18K |
| 94060 |
|
1,377 |
969 |
$17K |
| 82247 |
|
2,815 |
1,589 |
$16K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
774 |
537 |
$16K |
| 94729 |
|
1,293 |
917 |
$16K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
701 |
508 |
$15K |
| 71250 |
|
177 |
153 |
$15K |
| 73610 |
|
841 |
697 |
$14K |
| 94726 |
|
1,192 |
859 |
$14K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
536 |
389 |
$14K |
| 83735 |
|
2,194 |
1,573 |
$13K |
| 80050 |
General health panel |
271 |
269 |
$13K |
| 72100 |
|
551 |
430 |
$12K |
| 94761 |
|
976 |
595 |
$12K |
| 85379 |
|
1,550 |
1,229 |
$12K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
103 |
80 |
$12K |
| 87186 |
|
3,127 |
2,354 |
$12K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
106 |
63 |
$12K |
| 84702 |
|
1,172 |
818 |
$11K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,184 |
827 |
$9K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
95 |
80 |
$9K |
| 82150 |
|
1,642 |
1,333 |
$9K |
| 82550 |
|
1,859 |
1,476 |
$8K |
| 36600 |
|
376 |
248 |
$8K |
| 82553 |
|
1,124 |
975 |
$8K |
| 85027 |
|
2,045 |
1,390 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,704 |
1,367 |
$8K |
| 74018 |
|
513 |
367 |
$8K |
| 73030 |
|
503 |
400 |
$8K |
| 71020 |
|
497 |
449 |
$7K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
172 |
138 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,699 |
1,349 |
$6K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
281 |
223 |
$6K |
| 82565 |
|
451 |
389 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,147 |
890 |
$5K |
| 85610 |
|
2,039 |
1,498 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,303 |
2,536 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,405 |
772 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,105 |
2,439 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
103 |
80 |
$4K |
| 94760 |
|
505 |
328 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
30 |
29 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
99 |
78 |
$4K |
| 71010 |
|
622 |
542 |
$4K |
| 86900 |
|
838 |
594 |
$3K |
| 77002 |
|
108 |
62 |
$3K |
| 73110 |
|
160 |
126 |
$3K |
| 85730 |
|
595 |
421 |
$3K |
| 84439 |
|
253 |
177 |
$2K |
| 86850 |
|
229 |
146 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,434 |
1,035 |
$2K |
| 90715 |
|
118 |
103 |
$2K |
| 86141 |
|
209 |
173 |
$2K |
| 82248 |
|
294 |
206 |
$2K |
| 84436 |
|
294 |
250 |
$2K |
| 97597 |
|
98 |
52 |
$1K |
| 80179 |
|
85 |
58 |
$1K |
| 86140 |
|
352 |
212 |
$1K |
| 82009 |
|
284 |
222 |
$1K |
| 80143 |
|
67 |
45 |
$1K |
| 73502 |
|
61 |
39 |
$1K |
| 85651 |
|
343 |
256 |
$842.44 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
607 |
498 |
$820.48 |
| 84520 |
|
249 |
223 |
$785.23 |
| 84703 |
|
91 |
66 |
$755.74 |
| 83525 |
|
59 |
42 |
$608.99 |
| 82607 |
|
57 |
50 |
$584.06 |
| T1015 |
Clinic visit/encounter, all-inclusive |
103 |
83 |
$574.33 |
| 72040 |
|
28 |
24 |
$465.88 |
| 84134 |
|
29 |
24 |
$462.81 |
| 93971 |
|
20 |
13 |
$449.43 |
| J2704 |
Injection, propofol, 10 mg |
2,633 |
1,839 |
$426.79 |
| 82746 |
|
42 |
38 |
$375.69 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
533 |
455 |
$372.48 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
785 |
542 |
$343.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
291 |
219 |
$329.56 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
16 |
14 |
$286.00 |
| 74000 |
|
17 |
15 |
$270.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
316 |
288 |
$240.83 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
111 |
64 |
$240.27 |
| G0378 |
Hospital observation service, per hour |
602 |
374 |
$238.85 |
| 80185 |
|
14 |
13 |
$237.38 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,979 |
1,367 |
$203.41 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
18 |
12 |
$194.26 |
| 87045 |
|
15 |
14 |
$175.11 |
| J2060 |
Injection, lorazepam, 2 mg |
218 |
169 |
$164.38 |
| 87899 |
|
13 |
12 |
$141.57 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
77 |
50 |
$139.01 |
| 82272 |
|
75 |
51 |
$131.92 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
178 |
136 |
$125.95 |
| 86592 |
|
36 |
27 |
$114.61 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
309 |
211 |
$112.82 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
886 |
695 |
$112.12 |
| 87015 |
|
13 |
12 |
$104.94 |
| 80164 |
|
13 |
12 |
$96.70 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
104 |
67 |
$70.90 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,771 |
1,814 |
$58.11 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
230 |
107 |
$52.84 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15 |
14 |
$49.24 |
| 84100 |
|
20 |
14 |
$47.46 |
| 87046 |
|
13 |
12 |
$37.07 |
| 84156 |
|
26 |
24 |
$31.50 |
| 82570 |
|
13 |
12 |
$29.56 |
| 85018 |
|
37 |
17 |
$27.04 |
| 85014 |
|
34 |
14 |
$27.04 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,642 |
1,274 |
$11.40 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
140 |
124 |
$8.01 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,659 |
1,858 |
$0.03 |
| A9270 |
Non-covered item or service |
172 |
94 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
646 |
589 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
83 |
43 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
13 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39 |
29 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
15 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
248 |
161 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
13 |
12 |
$0.00 |